The CAPTIVATE trial of ibrutinib and venetoclax as a first line treatment for CLL patients
2 Jun 2018
The CAPTIVATE trial of ibrutinib and venetoclax as a first line treatment for CLL patients
Linking Lynch Syndrome and microsatellite instability in tumours
Editor’s Choice for May 2018
Movement and growth of cells throughout the leptomeningeal space
Diagnostics and classification of brain tumours
Funding collaborations and discovery in treating brain cancers
Incorporating biomarkers into clinical trial design
The evolution of imaging techniques for multiple myeloma
Diagnosis and management of smouldering myeloma
Editor's Choice for April 2018
Phase I taselisib results and a cell-free DNA assay
Impact of microbiome on head and neck cancers